FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086928 [Registered on: 14/05/2025] Trial Registered Prospectively
Last Modified On: 13/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Non-randomized, Active Controlled Trial 
Public Title of Study   An interventional study to evaluate the effect of shankupushppi choornam in premenstrual syndrome in participants with age group of 20-40 years. 
Scientific Title of Study   Effectiveness of Shankhapushpi churna in Premenstrual Syndrome  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrAiswarya Preman UV 
Designation  PG Scholar, Department of Prasutitantra and Streeroga 
Affiliation  Government Ayurveda college Thiruvananthapuram 
Address  Room no 2, Dept. of prasootitantra and streeroga Government Ayurveda Medical college. Thiruvananthapuram Kerala

Thiruvananthapuram
KERALA
695001
India 
Phone  9496785280  
Fax    
Email  aiswaryamalu13@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrAiswarya Preman UV 
Designation  PG Scholar, Department of Prasutitantra and Streeroga 
Affiliation  Government Ayurveda college Thiruvananthapuram 
Address  Room no 2, Dept. of prasootitantra and streeroga Government Ayurveda Medical college. Thiruvananthapuram Kerala

Thiruvananthapuram
KERALA
695001
India 
Phone  9496785280  
Fax    
Email  aiswaryamalu13@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Asha Sreedhar  
Designation  Professor and HOD Department of Prasutitantra and Streeroga 
Affiliation  Government Ayurveda Medical college and Hospital Pariyaram Kannur 
Address  Room no 2, Dept. of prasootitantra and streeroga Government Ayurveda Medical college. Thiruvananthapuram Kerala

Kannur
KERALA
670503
India 
Phone  9447893112  
Fax    
Email  drashaajith@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurveda Medical College and Hospital Thiruvananthapuram 
 
Primary Sponsor  
Name  Dr Aiswarya Preman UV 
Address  PG Scholar Government Ayurveda Medical college and Hospital Thiruvananthapuram  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aiswarya Preman UV  Govt Ayurveda college Hospital for Women and Children Poojappura Thiruvananthapuram  Dept of Prasutitantra and Streeroga OP no-2, Govt Ayurveda college,Thiruvananthapuram
Thiruvananthapuram
KERALA 
9496785280

aiswaryamalu13@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee (IEC)Government Ayurveda College,Thiruvananthapuram,Kerala,India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F59||Unspecified behavioral syndromes associated with physiological disturbances and physical factors. Ayurveda Condition: PMS,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: shankupushppi churna, Reference: charaka samhita chikitsa sthana rasayana adyaya karaprachitheeya pada, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: Yes(details: milk), Additional Information: -nil
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Participants whose menstrual cycle is regular with a duration of 2-6 days and 28 days of interval. Participants who are competent and willing to give written consent. Participants of age group 20-40 years diagnosed as Premenstrual syndrome using ACOG criteria with score 40 or above assessed by Premenstrual syndrome scale.
 
 
ExclusionCriteria 
Details  Participants undergoing prolonged medication for uncontrolled and chronic systemic illness. Participants with mood disturbances or any other psychiatric disorder. Participants with menopausal syndrome. Participants who are taking oral contraceptives and hormonal preparations. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in the score of Premenstrual symptoms assessed by premenstrual syndrome scale  0th day ,31st and 61st day 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="23"
Sample Size from India="23" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   25/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Premenstrual syndrome refers to regular monthly experience of physiological and emotional distress in women of reproductive age, usually during several days preceding menses. This syndrome is typically characterized by nervousness, depression, fluid retention. The premenstrual syndromes become typically obvious during the luteal phase of the menstrual cycle.In ayurveda this stage is correlates to Rituvyateetakala during which Pithakopa and vata sanchayam occurs. Shankhapushpi churna is Seeta veerya and Madhura vipaka hence it is vata pitta samana in nature. The objective of the study is to find the effect of Shankhapushpi churna in Premenstrual Syndrome. The study design will be interventional study pre and post test with a sample size of 23. Females of age group 20-40 years attending the out-patient department of prasutitantra and Streeroga, fulfilling the American College of Obstetrics and Gynecology criteria (ACOG) of Premenstrual syndrome will be selected for the study. Study tool includes ACOG criteria, Case proforma, and symptom assessment by Premenstrual syndrome premenstrual syndrome score scale. Shankhapushpi churna will be given in a dose of 6gm with 30 ml of milk twice daily after food. Administration of drug will be starting starting from 10th day of menstruation for 14 days in 2 consecutive menstrual cycles. Participants will be assessed on 0th day, 31 day and on 61st day during the study period. Result will be analyzed statistically and summarized to arrive at conclusions. 
Close